Clinical Trial Search

Primary: Time to the First Occurrence of the Composite Outcome of MI (Myocardial Infarction), Stroke, Cardiovascular Death, UA (Unstable Angina) or TIA (Transient Ischemic…

Primary: AIM 1: Change in Flow Mediated Dilation (FMD) (%) — -0.0012; 0.018; 0.014; 0.0053 percentage of arterial dilation change — p=0.943

Primary: Major Cardiovascular Disease Event — 3182; 527 Cardiovascular disease event

Primary: Vascular Endothelial Function — -294.4; -152.9; -102.9; -361.6 %FMD*min

Primary: Cardiovascular Disease Risk Factors — 3; 4; 5; 7 participants

Primary: Changes in Body Weight From Baseline — -1.88; -1.77 Kilograms

Primary: Predicted Annual Rate of Change in 10-year Risk of Fatal or Nonfatal Heart Attack or Stroke — -0.59; 1.66 annualized change in 10 year % cv risk — p=<0.05

Primary: New Participation in MOVE! (Among Women Aged 65 and Older) — 1.09 Odds Ratio — p=.003

Primary: LDL-C at Month 3 — 145 mg/dL — p=0.03

Primary: Low-density Lipoprotein Cholesterol (LDL-C) Levels at Baseline and Day 30 — 110; 84.0 mg/dL

Primary: Change in Body Mass Index BMI Percentile — -1.12; -0.08; -1.29; -0.73 BMI percentile

Primary: Change in Mean Systolic and Diastolic Blood Pressure (mm/Hg) From Baseline (Time 1) to Time 2 — -0.3; -2.4; 1.2; 2.2 mmHg

Primary: Percent Change in Postprandial Glucose Levels — 6.34; -9.83 Percent change from baseline — p==0.033

Primary: Changes to Body Fat Percentage as Assessed by DEXA Scan From Baseline to Day 70 Following Nic's Keto Diet — -2.25 percentage of body fat

Primary: Change From Baseline of Total Cholesterol After 90 Days — -0.57; -1.09 mmol/L — p=0.042

Primary: Mean Low Density Lipid-Cholesterol (LDL-C) Levels in High and Very High Risk Cardiovascular Participants — 2.40; 1.99 mmol/L

Primary: Vascular Endothelial Function — -195.9; -6.181; -5.629 %*min

Primary: Change in LDL From Baseline to 12 Months — 27.9; 25.1; 33.6; 25.1 mg/dL

Primary: Coronary Flow Reserve — 2.65 ratio

Primary: Difference in Mean Change in Prime Diet Quality Score Between Groups Between Months 0 and 6 — 1.22 Units on a scale

Primary: Reduction of the Estimated 10-year Total Cardiovascular Risk Score — 11.5; 11.1 percent

Primary: Ten Year Risk of Cardiovascular Disease (CVD) — 2.9 percentage of risk

Primary: Number of Participants With Visit to a Cardiology Specialist From Cohort — 283 Participants

Primary: Number of Subjects With Lipids Checked (Available Now Through National Laboratory Chain) or That Reported Having Their Lipids Checked by Their 1-week or 3-month Visit…

Primary: Global Framingham Risk Score — 11.5; 12.7; 9.9; 12.3 score on a scale

Primary: Systolic Blood Pressure — 127.0; 126.5 mm Hg — p=0.588

Primary: Eating Habits Confidence Survey — 4.2; 4.5 units on a scale

Primary: Comparative Outcomes: Intervention Group LDL Reduction Compared to Control Group LDL Reduction — 11.0; 11.1 % of patients with major LDL reduction — p=0.99

Primary: Low-density Lipoprotein Cholesterol — 100.1; 110.6 mg/dL — p=<0.001

Primary: Change From Baseline in Insulin Sensitivity at 4 Weeks — 0.28; -0.29 Calculated Ratio - No units